Utama › Kanser Kolorektal › Arizona › Scottsdale
Kajian klinikal Kanser Kolorektal di Scottsdale, AZ
16 kajian untuk Kanser Kolorektal sedang mencari peserta di lokasi dalam dan sekitar Scottsdale (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Mengambil pesertaFasa 1
- Honor Health Research Institute, Scottsdale
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Mayo Clinic, Scottsdale
- Ironwood Cancer & Research Centers, Scottsdale
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Mengambil pesertaFasa 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Mengambil pesertaFasa 1
- HonorHealth, Scottsdale
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Mengambil pesertaFasa 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Mengambil pesertaFasa 2
- Research Site, Scottsdale
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Mengambil pesertaKajian pemerhatian
- Mayo Clinic in Arizona, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Honor Health, Scottsdale
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Mayo Clinic (Arizona), Scottsdale
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Mayo Clinic, Scottsdale
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Mayo Clinic, Scottsdale
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Mengambil pesertaSukarelawan sihat dialu-alukan
- Mayo Clinic in Arizona, Scottsdale
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Mengambil pesertaFasa 1/2
- Clinical Trials Nurse Navigator, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Mengambil pesertaFasa 4
- Scottsdale Medical Imaging, LLC, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Mengambil pesertaFasa 1/2
- Mayo Clinic in Arizona, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1
- HonorHealth Research Institute, Scottsdale
Kajian Kanser Kolorektal di bandar lain
- Houston, TX102 kajian
- New York City, NY78 kajian
- Nashville, TN69 kajian
- Boston, MA63 kajian
- Los Angeles, CA59 kajian
- Arlington, VA52 kajian
- St. Louis, MO50 kajian
- San Antonio, TX46 kajian
- Philadelphia, PA44 kajian
- Grand Rapids, MI40 kajian
- Baldwin Park, CA37 kajian
- Chicago, IL34 kajian
Kajian lain di Scottsdale
- Kanser Payudara18 kajian
- Kanser (semua jenis)18 kajian
- Kanser Metastatik17 kajian
- Kanser Prostat17 kajian
- Kanser Paru-paru Bukan Sel Kecil15 kajian
- Kanser Pankreas13 kajian
- Melanoma10 kajian
- Kolitis Ulseratif8 kajian
- Kanser Paru-paru8 kajian
- Kanser Hati (Karsinoma Hepatoselular)7 kajian
- Penyakit Alzheimer7 kajian
- Kanser Payudara Triple-Negatif7 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.